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Biomolecular phenotyping 
and heterogeneity assessment 
of mesenchymal stromal cells using 
label‑free Raman spectroscopy
R. A. Rocha1,2, J. M. Fox3,4, P. G. Genever3,4 & Y. Hancock1,4,5,6*
Easy, quantitative measures of biomolecular heterogeneity and high‑stratified phenotyping are 
needed to identify and characterise complex disease processes at the single‑cell level, as well as to 
predict cell fate. Here, we demonstrate how Raman spectroscopy can be used in the difficult‑to‑
assess case of clonal, bone‑derived mesenchymal stromal cells (MSCs) to identify MSC lines and group 
these according to biological function (e.g., differentiation capacity). Biomolecular stratification 
is achieved using high‑precision measures obtained from representative statistical sampling that 
also enable quantified heterogeneity assessment. Application to primary MSCs and human dermal 
fibroblasts shows use of these measures as a label‑free assay to classify cell sub‑types within complex 
heterogeneous cell populations, thus demonstrating the potential for therapeutic translation, and 
broad application to the phenotypic characterisation of other cells.
The ability to accurately and quantitatively assess molecular-scale differences at the single-cell and cell-population 
levels is of immense importance in biomedical research. No two cells are the same, with cell-level variations 
typically found in normal cell-populations due to spontaneous genetic differences upon cell division, or from 
environmental factors, such as epigenetic  modifications1,2. Even clonal populations consisting of cells derived 
from the same parent-cell have been found to exhibit cell-level  differences1–3, with these also being important 
in the study of diseases that manifest at the single-cell level, such as cancer. Although the quantification and 
stratification of inter- and intra-cell heterogeneity are challenging, these remain key to understanding disease 
processes, including disease initiation, as well in the development of diagnostics and  treatments4,5.
Cellular heterogeneity is typically assessed using microscopy and flow cytometry, which are not label-free6. 
DNA and RNA sequencing, and gene microarray technologies, have advanced cell assessment; however, these 
methods are data-intensive, involve detailed sample preparation via multi-step processes, are time-consuming 
and relatively  costly7. Gawad et al.8 and Lo and  Zhou9 provide detailed reviews of the state-of-the-art in single-
cell genome sequencing, where the enormity of the challenge in determining and comparing full cell-level 
information is relayed. The relationship between the cell genotype and phenotype is also challenging to  assess10. 
For example, it is difficult to ascertain whether all relevant gene-level information has been captured in the 
characterisation of cell-level disease. Changes to cellular expression, i.e., phenotypic plasticity, may also result 
from treatment-related genetic-scale  changes11. From these examples alone, the enormity in developing tractable, 
quantitative assessment and phenotyping of cell-level and population-level heterogeneity, and the relationship 
of these factors to accurate assay development, is apparent.
To assist with these challenges, spectroscopic methods, such as Raman spectroscopy (RS), are being developed 
and assessed as complementary routes for molecular-level characterisation of intra- and inter-cellular properties. 
The Raman effect results from single photon-molecule, inelastic scattering (UV, visible or near-IR laser light) 
that causes a change in polarisability and vibrational state of the molecule. The scattered light is assessed spec-
troscopically, providing a highly-sensitive, detailed molecular-scale fingerprint of the sample. RS is advantageous 
as it requires little sample preparation, is label-free, and can be used non-destructively. The method has been 
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extensively applied to study biological samples down to single-cell interrogation (e.g., Baldock et al.12), with its 
ability for sensitive molecular-level characterisation being well-established (e.g., Movasaghi et al.13). Its use in 
translational biomedical applications could be further expanded by the development of easy-to-prepare Raman-
based assays for stratified phenotyping, created from rigorous data analyses, and verified by reproducibility tests 
via robust statistical assessment.
As proof-of-concept of this approach, we have applied RS to quantitatively characterise clonal mesenchymal 
stromal cells (MSCs)14 using easy-to-prepare, dried-cell samples. MSCs have been used in clinical trials for cell-
based therapies to treat a range of disorders including chronic orthopaedic disorders, such as osteoarthritis and 
 osteoporosis15. However, their application in regenerative medicine has been compromised by the inability to 
reliably and easily identify these cells in highly heterogeneous populations, and to definitively characterise their 
subtype properties (such as differentiation potential) using cell surface markers, or by  profiling16,17. Here, we 
show label-free RS can be used for biomolecular phenotyping and cellular heterogeneity assessment of MSCs, 
thereby enabling MSC identification within mixed-cell populations and stratification according to shared bio-
logical features. The potential to predict specific cell properties, for example, differentiation capability, may also 
ensue. Such Raman-based measures could be applied as an assay, specific for future therapeutic translation of 
MSCs in regenerative medicine, and more broadly, to phenotype, and assess heterogeneity in other cell-types 
pertinent to the fields of biology and biomedicine.
Results
Raman spectra show key visual differences across cell lines. The MSC lines in this study were 
generated by isolating single-cell-derived colonies from a heterogeneous MSC population that was immortal-
ised with human telomerase reverse transcriptase (hTERT)14. Four hTERT MSC-lines, Y101, Y102, Y201 and 
Y202, were chosen with Y101 and Y201 having tri-lineage differentiation capacities, and with Y102 and Y202 
being differentiation incompetent (Table  S1). The Raman spectra for the hTERT MSCs were tested for cell-
type discrimination and the ability to group Y101/Y201 vs. Y102/Y202 due to these groups having previously 
defined, shared biological features, such as morphologies, immunomodulatory capacities and differentiation 
 competencies14. A primary, FACS-sorted MSC sub-set expressing the surface protein, CD317 (CD317+MSCs), 
which has been shown to have similar features (morphology and immunomodulatory capacity) to the Y102/
Y202 non-differentiating cell-lines14, was compared as an independent assessment. As MSCs are found in highly 
heterogeneous mixed-cell populations, a human dermal fibroblast (HDF) cell-line also served as a non-MSC 
stromal cell control.
Averaged Raman spectra and corresponding standard error of the mean (SE) envelopes for the undifferenti-
ated hTERT MSCs (Y101, Y201, Y102 and Y202), primary CD317+MSCs and HDF cell populations are shown 
in Fig. 1a. Each averaged spectrum is a statistically-converged representation of the cell population with respect 
to twice the standard deviation (2×SD) and SE (Figs. S1–S7). The representative peak-positions were obtained 
by averaging across the peak-position values for the hTERT MSC-lines, as these comprise the reference spectra 
against which other cell types were compared (see Table S2 for the full range of peak positions across all cell-types 
studied in this work). Biomolecular peak assignments were found from literature comparisons with detailed 
information about the Raman-active modes given in Table S3.
Key visual differences across the spectra are apparent about the protein band centred at 932 cm−1 , the protein 
and DNA/RNA band at 971 cm−1 , as well in the convolved lipids, phospholipids, carbohydrates and DNA/RNA 
region resolved at 1060 cm−1 and 1085 cm−1 . The DNA/RNA nucleic acid bands at 779 cm−1 and 1573 cm−1 are 
also more distinct in the HDF spectrum compared to how these bands appear in the spectra for the other cell 
types. The most marked difference across the hTERT MSC-lines occurs in the region containing the 932 cm−1 
and 971 cm−1 bands, corresponding to protein, and protein and DNA/RNA vibrations, respectively.
Multivariate methods show variances that stratify the hTERT MSCs. Figure 1b–d show the prin-
cipal component analysis (PCA) loadings for the first three principal components PC1, PC2 and PC3, which 
account for 32%, 22% and 12% of the variance, respectively. The loading results indicate background differences 
between the spectra, with PC1 showing distinct features between the four hTERT MSC-lines. The loadings also 
confirm the key visual differences between the spectra, with PC1 showing marked variance across the hTERT 
MSCs in the 932  cm−1 and 971  cm−1 band regions, as well as in the region containing the 1060  cm−1 and 
1085 cm−1 bands.
As PCA was unable to fully discriminate the hTERT MSCs (Fig. S8), a subsequent linear discriminant analysis 
(PCA-LDA) was performed, which discriminated the four hTERT MSC-types (Fig. 1e). The PCA-LDA results 
show the Y101 and Y201 cells to be well-separated, with the linear discriminant component LDF3 showing good 
distinction between the Y102 and Y202 cell-types. The Y101s are most clearly separated from the other three 
cell-types, which may indicate their ability for spontaneous osteogenic differentiation—this being their most 
biologically distinct feature. The PCA-LDA results were cross-validated using leave-one-out cross-validation, 
resulting in an overall 84% prediction accuracy in determining the individual hTERT MSCs (Table S4). A pre-
dictive classification of 94.6% for the Y101 and 69.5% for Y201 differentiation-competent cells was obtained. 
For the Y102 and Y202 differentiation-incompetent cells, there was a 70% prediction accuracy for Y102 and 
80.6% prediction accuracy for Y202, with some mixed identification. Hence, the multivariate results confirm 
the sensitivity of RS to classify the hTERT MSCs according to shared biological features, as well as distinguish 
with reasonable predictive accuracy, the four MSC-types.
hTERT MSC ratiometric biomarkers stratify individual cell‑lines and those with shared bio‑
logical features. The Raman spectra were tested for further discriminatory potential using univariate, peak 
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intensity ratio (PIR) analyses. By assessing all-peaks-against-all-peaks in each average hTERT MSC spectrum 
(Fig. 1a), the PIRs that separate the Y101/Y201 and Y102/Y202 groups, as well as fully discriminate the cell lines, 
were identified (Fig. 2). Here, ‘fully discriminate’ means complete separation of the PIRs for each MSC-type 
outside of the SE uncertainties (error bars).
Discriminatory PIR profiles for the biologically-well-defined hTERT MSCs provide sets of panels against 
which other cell types can be compared. PIRs that fully discriminate the cell lines correspond to proteins, 639/932 
(Fig. 2a), as well as those relative to the 971 cm−1 band (proteins and DNA/RNA) (Fig. 2b, and also 971/1085 and 
Figure 1.  (a) Averaged Raman spectra obtained from the cell nuclei of the four hTERT MSCs, primary 
CD317+MSCs, and HDF cell-populations in the ‘fingerprint’ region (600–1800 cm−1 ), where N is the total 
number of individual spectra in each spectral average. The SE envelopes associated with each spectrum are 
shown in grey. Peak positions were averaged across the hTERT MSCs giving the representative values in the 
figure. Table S2 shows the peak-position ranges for all of the cell types studied in this work, with detailed 
biomolecular peak-assignments given in Table S3. The spectral resolution was ± 3 cm−1 . PCA loadings 
corresponding to the (b) PC1, (c) PC2 and (d) PC3 principal components across the four hTERT MSC-
types (cf. Fig. S8), which capture 32%, 22% and 12% of the total variance, respectively. Key points of variance 
above the background in the PC1 loadings correspond to visual differences seen in the average spectra in 
(a). Univariate analyses involving peak intensity ratios (PIRs) will show that the bands identified in blue have 
specific discriminatory capabilities. (e) PCA-LDA scatterplots for the hTERT MSCs generated by capturing 
91% of the PCA variance. Cell-line discrimination using the first three linear discriminant functions (LDFs) 
is shown. An 84% overall prediction accuracy in determining the hTERT cell-types from these results was 
achieved using leave-one-out cross-validation.
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Figure 2.  (a)–(f) hTERT MSC population comparisons (Raman biomarker panels) for the Y101, Y201, Y102 
and Y202 cell-lines showing the PIRs that discriminate the Y101/Y201 differentiating vs. Y102/Y202 non-
differentiating cell-types, and identify individual hTERT MSC-lines. The uncertainties are the converged 
propagated standard error of the mean associated with each PIR measurement.
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971/1445 in Fig. 2d,e, respectively). PIR panels that predominantly distinguish shared biological features of the 
MSCs by separating the Y101/Y201 and Y102/Y202 differentiating vs. non-differentiating cell-lines were found 
relative to the 1060 cm−1 band corresponding to DNA/RNA, carbohydrates, lipids and proteins (Fig. 2c), and 
the 1473 cm−1 band relating to protein, lipids, DNA/RNA (Fig. 2f). The 932 cm−1 (protein), 1085 cm−1 (DNA/
RNA, carbohydrates, lipids and proteins) and 1445 cm−1 (lipids and proteins) panels also show Y101/Y201 and 
Y102/202 stratification (Fig. 2a,d,e). Across all of these panels, the most discriminatory markers for determin-
ing differentiation competency by absolute magnitude differences involve protein and protein-lipid signatures, 
namely, the 999/1060, 1445/1060 and 1654/1060 PIRs (Fig. 2c), therefore confirming the PCA findings that key 
differences occur due to protein, lipid and DNA/RNA variations.
hTERT MSC Raman biomarker panels classify other cell types. The PIRs from FACS-sorted prima-
ries (CD317+MSC) were compared against the hTERT MSC panels, which showed these to be predominantly 
aligned with the non-differentiating Y102/Y202 cell-lines (Fig.  3). The 971  cm−1 PIR panel (discriminatory 
across all MSC lines) was also closely aligned to Y102 (Fig. 3b). To quantify this match, K-nearest neighbours 
(KNN) classification was performed (Fig. 3g), which determined an overall 82% classification match against the 
Y102/Y202 PIRs assessed across all of the comparison panels (Fig. 3a–f and Table 1). For the 971 cm−1 panel that 
stratifies cell-type, the KNN results showed the CD317+MSCs to be most closely matched at 85% to Y102, with 
an overall 92% match against the Y102/Y202 cell-lines as assessed over all available 971 cm−1 PIRs (Fig. 3g). 67% 
of the 971 cm−1 hTERT MSC PIRs were found to be matched within uncertainty (Table S5).
The hTERT MSC panels were also compared against those determined for adult HDFs as a non-stromal 
cell control (Fig. 4). MSCs have similar morphologies and properties to fibroblasts, a common type of stromal 
 cell18,19. Recent evidence indicates that MSCs and fibroblasts are phenotypically  indistinguishable20. This finding 
corresponds with what is known about HDFs kept in standard culturing conditions, namely that they have no 
potential for tri-lineage differentiation (see for example, Pittenger et al.21). Across the panels that correlate to 
differentiation competency, the HDFs showed overall similarity with the differentiation-incompetent Y102/Y202 
cell-lines. KNN-classification against the 971 cm−1 individual cell-line panel shows the HDFs to be most closely 
matched at 60% to Y202, with a 67%-match across both the Y102 and Y202 cell-lines (Fig. 4g). In total, 92% of 
the 971 cm−1 hTERT MSC markers matched within uncertainty (Table S6). An overall 72% KNN-match against 
the non-differentiating Y102/Y202 cell-lines assessed across the full panel set was obtained (Fig. 4g; Table 1). 
Compared to the CD317+MSCs, the HDFs have different relative Y101/Y201 and Y102/Y202 %-classification-
matchings, hence they are phenotypically distinct (cf. Figs. 3g, 4g, also Table 1).
Primary-derived MSC populations are highly heterogeneous groups containing cells of different phenotypes 
and progenitor characteristics (differentiation capacities)16,18,19. Here, we use the hTERT MSC clonal panels to 
characterise Raman maps of individual primary MSCs (designated K72) obtained from a bone-derived MSC 
population. Figure 5a shows the converged averaged spectrum from each Raman cell map (see also Figs. S6 and 
S7), together with the corresponding single-cell optical image. K72 cells 2 and 3 have similar optical features, 
which are reflected also in spectral similarities, such as the pronounced spectral feature about the 971 cm−1 band.
PIR biomarker panels derived from the average spectra for each single-cell map were compared against the 
hTERT MSC panels (Figs. S9, S10 and S11). KNN-classification against the 971 cm−1 individual cell-line panel 
shows the K72 cell 1 to have a 53% match against the Y102/Y202 cell-lines, with 83% of the total markers for this 
panel matching within uncertainty (Fig. 5b; Table S7). K72 cells 2 and 3 are significantly Y101-dominant in the 
971 cm−1 panel having 100%-matches (Fig. 5c,d; Tables S8, S9). Assessed across all of the hTERT MSC panels, 
the results indicate mixed hTERT features for the individual K72 primary cells (Fig. 5b–d). K72 cell 1 is largely 
matched with the Y102/Y202 hTERT cell-lines (58% overall), whereas K72 cells 2 and 3 are Y101/Y201 dominant 
(73% and 55%, respectively) (Table 1). Against the K72 primary MSCs, the HDFs (non-stromal control) also 
remains phenotypically distinct (cf. Figs. 4g, 5b–d; Table 1).
PIRs show good reproducibility across replicate experiments. Reproducibility of the PIRs was 
tested across experimental replicates. The 1085 cm−1 PIR panel, which distinguishes the differentiating hTERT 
MSCs (Y101/Y201) and non-differentiating hTERT MSCs (Y102/Y202), shows good reproducibility across the 
hTERT MSC experimental repeats (e.g., Fig. 6a; Fig. S12a–d). Good reproducibility was also obtained for the 
population and single-cell map comparisons for a Y101 cell-line, CD317+MSCs and K72 primary cells (e.g., 
Fig. 6b; Fig. S12e–g). A greater number of repeats were performed for the Y101 cell-line (six replicates) due to its 
ability to spontaneously  differentiate14. Only one of the replicates (Y101 p64; where p = passage) showed marked 
differences against the other Y101s in the 1085 panel, specifically for the 971/1085 PIR (Fig. 6a). Differences were 
also seen in the 971/1085 PIR for the K72 cell 1 and the K72 population against the K72 cells 2 and 3 (Fig. S12g). 
These differences were represented more specifically in the KNN analysis, which showed the K72 cell 1 to have 
a greater similarity to Y102/Y202 cell-types, compared to the K72 cells 2 and 3, which were found to be more 
Y101/Y201-like (Table I) by having variations in the 971/1085 PIR marker. The 971 cm−1 panel was examined 
due to the sensitivities observed with the reproducibility of the 971/1085 PIR, as well as it being distinguishing 
of the hTERT MSCs; thus, it was expected to show the greatest differences across replicate comparisons. Such 
differences were indeed apparent for this marker in various degrees in the reproducibility results for the hTERT 
MSCs, and in the individual cells vs. population reproducibility panels (Fig. 6c; Fig. S13). For example, the Y101s 
show the greatest differences across experimental repeats (Fig. 6c) compared to the FACS-sorted CD317+MSC 
population vs. individual cell comparisons (Fig. 6d).
Raman maps show spatially‑resolved heterogeneity linked to differentiation capaci‑
ties. Raman maps were constructed from spatially-resolved 1654/1085 PIR values as this marker discrimi-
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Figure 3.  (a)–(f) PIRs comparing the CD317+MSCs against the hTERT MSC biomarker panels. The 
uncertainties correspond to the propagated standard error of the mean. The CD317+MSCs show a close 
match to the Y102/Y202 cell-lines, which aligns with them being biologically-similar as per Ref.14. (g) KNN-
classification across all of the comparison panels confirms a total Y102/Y202 contribution of 82% (Table 1). For 
the 971 cm−1 panel (b), which stratifies cell-type, the KNN results in (g) shows the CD317+MSCs to be most 
closely matched at 85% to Y102.
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Figure 4.  (a)–(f) PIRs comparing the HDFs against the hTERT MSCs. The uncertainties correspond to the 
propagated standard error of the mean. For the 971 cm−1 panel, which stratifies cell-type, the HDFs are most 
closely KNN-matched at 60% to Y202 (b,g). Under standard culturing conditions, HDFs are expected to be 
differentiation  incompetent21, which is indicated here by the close (72%) Y102/Y202 match shown in (g) 
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nated between the Y101/Y201 (differentiating) and Y102/Y202 (non-differentiating) cell-lines (Fig.  2d). The 
1654/1085 PIR also showed good reproducibility in the replicate tests across the average spectra (Fig.  6a,b; 
Fig. S12). Good reproducibility for this marker was also obtained for the Raman maps due to robustness in the 
auto-fitting of the 1085 and 1654 bands in each individual spectrum against other bands that were difficult to 
resolve at single-spectrum-level due to low signal-to-noise. The 1654/1085 PIR shows marked spatial differences 
in the map results, such as morphological changes (shapes and sizes) between the nuclei for the dried hTERT 
MSCs (Fig. 7). For example, nuclei of the Y101/Y201-type cells have smaller areas and elongated shapes versus 
the larger, rounded nuclei of the Y102/Y202-type cells (see Fig. S14 for DAPI results).
The 1654/1085 PIR values in the Raman maps have a relatively even distribution over the Y101/Y201 nuclei 
compared to the Y102/202 nuclei, which have concentrated regions of higher 1654/1085 PIR-values assumed to 
be within the nucleoli of the cell (cf. Fig. 7a,b with Fig. 7c,d). Oktar et al. reported a link between nucleoli absence 
or presence associated with nucleostemin expression, and the resultant differentiation capability (differentiating 
or non-differentiating, respectively) of  MSCs22. These findings are commensurate with the Raman maps, namely 
that the Y101/Y201-type cells, which are differentiation competent, have an absence of well-defined nucleoli, 
whereas Y102/Y202-type cells, which are differentiation incompetent, have highlighted nucleoli regions via the 
1654/1085 PIR marker. The percentage frequency of occurrence of 1654/1085 PIR values normalised against the 
total number of spectral measurements for each cell nuclei is shown in Fig. 7e, providing a succinct representa-
tion of the Raman map results. The Y101/Y201-type cells have lower, more consistent 1654/1085 PIR values 
across the nuclei, whereas Y102/Y202-type cells have, in general, higher 1654/1085 PIR values with a broader 
numerical range across the cell nuclei.
Biomolecularly‑stratifed heterogeneity can be quantified via statistical convergence. Hetero-
geneity across each cell-line population can be assessed via the rate-of-convergence of the percentage standard 
error (%SE) as a function of the increasing number of spectra collected for each cell-line added to the fingerprint 
average, and then stratified to specific PIRs. We assessed the convergence of the two previously studied ratios; 
971/1085, which discriminates the four MSC lines, and the 1654/1085 PIR, which shows separation between 
differentiation-competent Y101/Y201 cell-lines, and the differentiation-incompetent Y102/Y202 cell-lines. For 
both PIRs, the %SE was calculated and plotted against the number of averaged spectra. An example of a %SE 
convergence test is shown in Fig. 8. The convergence graphs were fitted with an exponential curve from which a 
decay constant tau ( τ ) was derived as a measure of the heterogeneity associated with each population and strati-
fied biomarker (Figs. S15–S20).
Table 2 shows the average decay constants for the cell populations corresponding to the 971/1085 and 
1654/1085 PIRs. A smaller τ indicates a more “rapid decay” of the exponential curve, meaning the PIR has 
converged to a minimum value of the %SE using a smaller quantity of spectra from across the population. Thus, 
τ can be used to stratify and assess heterogeneity for each PIR, with a smaller value indicating a more homo-
geneous population. For the 971/1085 PIR (protein and DNA/DNA ratio), the average τ for the hTERT MSCs 
was found to be smaller than the other cell-types, specifically, the HDF and K72 populations, indicating greater 
homogeneity. The CD317+MSC primaries, having been sorted by FACS, were the most homogeneous for the 
971/1085 marker with a decay constant of 7 ± 1; however, only one experiment was performed. Similar results 
were obtained for the 1654/1085 PIR (proteins and lipids/DNA ratio), which showed the hTERT MSC τ ’s to also 
be, on average, smaller than the average τ across the other cell-types.
Discussion
Understanding cell-level processes that underpin cellular function at the biomolecular-level, including cell-level 
disease, is paramount to advancing the fields of biological and biomedical research. The role of cellular hetero-
geneity in phenotypic characterisation, and the ability to easily and tractably quantify and stratify this to the 
biomolecular-level, remain open challenges. Such understanding, linked to cellular function, could positively 
impact biomedical applications, for example, in developing cell-level disease treatments through the selection 
and assessment of cells for downstream testing. Here, we have shown how Raman spectroscopy can be used to 
create an easy, high-discriminatory and tractable means of stratified phenotyping and quantifying cellular het-
erogeneity at the biomolecular-level based on representative and robust statistical sampling using an exemplar 
case of closely-related clonal MSCs.
To demonstrate this application, sets of Raman PIR biomarkers were obtained for four well-characterised 
clonal hTERT MSC-lines derived from statistically-converged spectral data. For cellular phenotyping, the 
Table 1.  Cell-type matches (%m ) obtained from a KNN model where the closest-distance match between PIR-
means in each hTERT MSC panel have been accounted for and then determined across all panels.
Cell type %m Y101 %m Y102 %m Y201 %m Y202 %mY101/Y201 %m Y102/Y202
CD317+MSCs 14% 43% 4% 39% 18% 82%
HDFs 15% 25% 13% 47% 28% 72%
K72 cell 1 21% 23% 21% 35% 42% 58%
K72 cell 2 44% 13% 29% 14% 73% 27%
K72 cell 3 38% 26% 18% 18% 55% 45%
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sensitivity of Raman to characterise these closely-related cell-lines was demonstrated by it eliciting 90 biomark-
ers across six PIR panels that stratified the clonal hTERT MSC-lines and grouped according to known, shared 
biological functions (e.g., differentiation competencies) (Fig. 2). The stratifying biomarkers were related to bio-
molecular differences, namely, to spectral regions sensitive to differentiation-capacity distinction, specifically 
DNA/RNA, protein and lipid changes. Unsupervised, multivariate PCA and PCA-LDA validated the univariate 
Figure 5.  (a) Average fingerprints comprising 36 spectra/individual cell map for each of the primary K72 
cells circled in the corresponding optical images (cells 1, 2 and 3, respectively). Scale bar = 20 µ m. (b)–(d) 
KNN-classified, % hTERT MSC contributions associated with each individual cell as determined across all PIR 
markers for each individual panel (Figs. S9–S11). For the 971 cm−1 panel, which stratifies cell-type, the K72 cell 
1 is most closely matched at 53% to the Y102/Y202 cell-lines. The K72 cells 2 and 3 have 100% matches against 
Y101. Assessed across all panels and markers, the K72 cell 1 has an overall 58% match against the Y102/Y202 
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PIR results with an overall 84% prediction accuracy in individual cell-line identification determined by leave-
one-out cross-validation.
To test the sensitivity and accuracy of the hTERT PIR panels for cellular classification, comparisons were 
made against those determined for primary cell-sorted MSCs (CD317+MSCs) expressing the CD317 protein, 
which have been shown to be related to the non-differentiating Y102/Y202 hTERT  MSCs14. Human dermal 
fibroblasts (HDFs) were also compared as a non-MSC stromal control. Following KNN-classification against 
the hTERT MSC panels, the CD317+MSCs were correctly identified to be most closely matching to the Y102/
Y202 hTERT MSCs (82% match), with the HDFs being phenotypically distinct (Table 1). Previously, we had only 
shown a very limited set of biomarkers and spectral data, with no  replicates14. In a further application, the PIR 
biomarker panels for three randomly-selected, primary MSCs were also assessed and classified against hTERT 
MSC panels, thereby determining their phenotypic likeness. These findings show the ability to use Raman to 
generate biomarker panel-sets from biologically well-defined cells (in this case, clonal MSCs) that can be used 
to identify and characterise key features of more complex and heterogeneous cell-types, such as primary cells of 
the same type, or against different cells that can be found in mixed, heterogeneous populations.
A benefit of Raman testing, as shown here, is the ability to use this information to understand cell-function 
and cell-variations via stratified biomolecular differences. In terms of specific biomolecular differences in this 
exemplar case, the 971 cm−1 band, which originates from the vibrations of phosphate monoester groups in phos-
phorylated proteins and DNA/RNA nucleic  acids13,23, was shown to stratify the four hTERT MSC-lines (Fig. 2b). 
Specific, functional pathways relating to this band include increased protein phosphorylation occurring via pro-
tein kinase C δ , which has been associated with differentiation  capacity24, and hyper-phosphorylation of proteins 
in MSCs in the undifferentiated state detected by phosphoproteomic  studies25. Protein phosphorylation is also 
linked to cell signalling that occurs in response to external  factors26, is regulatory in cell death  mechanisms27 and, 
together with downstream DNA/RNA changes, is associated with cellular modifications due to  desiccation28. 
Thus, a partial explanation for the significance of the 971 cm−1 band in cell-line discrimination may also be 
biomolecular changes from air-drying or cell death that further enable stratification capability.
Reactive oxygen species production, which leads to changes in proteins, lipids and DNA via phosphoryla-
tion and cell  desiccation29 have also been implicated in differentiation capacity differences in  MSCs30. Protein 
sensitivity in the hTERT MSC PIR panels is further supported by proteomic  studies31, and by protein-specific 
genetic pathways in MSCs, such as Wnt protein signalling-induced osteo-differentiation32. All of these factors 
Figure 6.  Reproducibility tests for the 1085 cm−1 and 971 cm−1 PIR panels between experimental replicates 
for the (a), (c) Y101 MSC-line showing different passages, p, and (b), (d) for the FACS-sorted, primary 
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Figure 7.  Spatially-resolved Raman maps showing the 1654/1085 PIR that separates the Y101/Y201 
(differentiation competent) and Y102/Y202 (differentiation incompetent) hTERT MSC-lines. The 
differentiation-competent (a) Y101 and (b) Y201 cells have low, evenly distributed values for this marker, 
whereas the differentiation-incompetent (c) Y102 and (d) Y202 cells show concentrated “hot-spots” assumed to 
be within the cell nucleoli. (e) Percentage frequency of occurrence corresponding to the 1654/1085 PIR values 
measured over the spatially-resolved Raman maps showing discrimination of the Y101/Y201 and Y102/Y202 
differentiation competencies. The values were normalised against the number of individual spectra (N) obtained 
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may relate to the high number of protein-related Raman markers for MSC characterisation. Lipid-specific mem-
brane compositions pertaining to different cell-lines and their recent implication in MSC differentiation  fates33 
may additionally explain lipid involvement in the PIR panels. The predominance of protein, lipid and DNA 
signatures is represented across the key bands found at 932 cm−1 , 971 cm−1 , 1060 cm−1 , 1085 cm−1 , 1445 cm−1 
and 1473 cm−1 (Fig. 1). The ability to link phenotypic expression to underlying function, as demonstrated here, 
which stem from stratified biomolecular differences, could also be applied more broadly to other cell systems 
across the fields of biology and biomedicine, for example, to study cell-level disease processes, and in applica-
tions involving cell selection, diagnostics, or to monitor cell response in the development of targeted treatments.
A key aim of this work was to propose a means by which cellular heterogeneity could be biomolecularly 
quantified and stratified. In this respect, we have shown various ways by which statistically-converged Raman 
data can be easily used for this purpose. In our example case, the Raman biomarker maps of the hTERT MSCs, 
which contained a statistically-representative amount of spatially-resolved point spectra, provided further phe-
notypic distinction for the 1654/1085 PIR biomarker that stratified the differentiating and non-differentiating 
(Y101/Y201 vs. Y102/Y202) MSCs types (Fig. 7). These maps also highlighted morphological differences in the 
sizes of the nuclei found to be in general agreement with DAPI experiments of the nuclei perimeters and areas 
of the hTERT MSCs (Fig. S14). The spatially-resolved Raman information therefore provides greater detail by 
which spatial heterogeneity linked to functional differences can be assessed.
Reproducibility tests for the PIR biomarkers across replicates also showed how heterogeneity could be strati-
fied and quantified to individual PIR markers. Although both the 971/1085 PIR (which stratified cell-type) 
and 1654/1085 PIR (which stratified cell-function, e.g., differentiation capacity) showed very good replicate 
Figure 8.  Example percentage standard error (%SE) convergence test showing the “decay” of the %SE 
associated with the 1654/1085 PIR as a function of increasing, randomly-acquired spectra added to the 
spectral average. A convergence test such as this can be used to derive a decay constant (tau/τ ), interpreted as 
a quantitative measure of heterogeneity stratified to specific PIRs. The red line shows the fitted exponential 
function.
Table 2.  Average decay constants ( τ ) obtained for the 971/1085 and 1654/1085 PIRs for the different cell 
populations analysed, together with the number of experiments performed. These summarised results have 
been extracted from Figs. S15–S20 and Tables S10–S17. A smaller τ represents a more “rapid decay” of the 
%SE. For the hTERT MSC-lines (Y101, Y201, Y102 and Y202), the range of τ values are shown in the brackets. 
For the other cell types, the uncertainty corresponds to the standard deviation of the exponential fitting since 
these experiments were performed only once. As the CD317+MSCs were sorted by FACS, the average (Av.) 
decay rates were also shown for the primaries with their results removed.
PIR 971/1085 PIR 1654/1085
Sample Replicates Av. decay constant ( τ) Av. decay constant ( τ)
Y101 6 10.0 (6.2–14.0) 7.7 (4–12)
Y201 2 8.5 (5.7–11.6) 3.5 (2.2–4.6)
Y102 2 8.5 (5.5–12.0) 7.5 (6–9)
Y202 2 11.5 (10.0–12.7) 6.5 (4–8)
Average (hTERTs) — 9.6 6.3
CD317+MSCs (pop) 1 7 ± 1 8 ± 1
HDF(pop) 1 13 ± 1 8 ± 1
K72(pop) 1 10 ± 1 6.0 ± 0.9
Average (others) — 10 [11.5 sans CD317+MSCs] 7 [7 sans CD317+MSCs]
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reproducibility, the former indicated greater variation (i.e., heterogeneity) across the replicates (Fig. 6; Figs. S12 
and S13). We believe these variations to be primarily related to the overall differences in the MSC differentiation-
potential across the hTERT MSCs. Statistical convergence tests, where the %SE was converged as a function of 
the increasing number of spectra in the spectral average, confirmed the 971/1085 PIR, which stratifies cell-type, 
to also have greater biomolecularly-resolved heterogeneity compared to the 1654/1085 PIR across the cell-line 
populations. These comparisons were made via a proposed heterogeneity-measure determined from the rate of 
convergence ( τ ) (Fig. 8). If linked to cell-fate and biological function, biomolecularly-stratified heterogeneity 
measures, such as these, could be used to engineer more phenotypically-homogenous populations of cells for 
specific purposes. For the MSCs, this could mean selecting the best choice of cells for specific and directed differ-
entiation, ensuring sufficient MSCs within a population to produce large-scale and targeted tissue development; 
another issue limiting their biomedical translation and therapeutic purpose.
In summary, we obtained Raman PIR panels comprising a complete set of distinct biomarkers for clonal 
hTERT MSCs that correlate to what is known about the differentiation competencies of each cell-type, with a sub-
set that fully distinguishes the cell lines. Using these panels, we were able to classify and identify other cell types, 
and via statistical convergences, assess and quantify biomolecular-level stratified heterogeneities. Compared to 
more complex classification methods, which require substantial sample preparation, we propose a means by 
which a statistically robust, univariate, Raman spectroscopy assay can be derived. Such an assay would be label-
free, rich in information for precision stratification, and easy to produce and measure. Using these methods, 
Raman-based assays could then be derived for other cell systems (both dried and live cell, and for tissues), seeing 
broad application within the fields of biology and biomedicine, and overcoming current limitations in obtaining 
quantitative and biomolecularly-stratified phenotyping and assessment of heterogeneity linked to cell function.
Methods. All methods were carried out in accordance with relevant guidelines and regulations under 
approval from the University of York Biology Ethical Committee and NHS Local Research Ethics Committee.
Cell culturing. Primary MSCs were obtained from tissue samples removed during routine joint replace-
ment therapy. Informed consent was obtained from all subjects and all methods were carried out in accordance 
with relevant guidelines and regulations. Protocols for obtaining and characterising the hTERT MSC lines and 
acquiring the CD317+ fraction from a primary MSC population using FACS can be found in Ref.14. Human 
dermal fibroblasts (HDFs) were purchased from Cascade Biologics (Life Technologies). Cells were grown at 
37 ◦ C and 5% CO2 in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% penicillin–streptomycin. Fetal 
bovine serum (FBS) was supplemented at 10% for the hTERT MSC clonal lines and the HDFs, and at 15% for the 
primary MSCs (CD317+MSCs and K72). At ∼70% confluence, the growth medium, including any non-adherent 
cells, were removed and the cells rinsed with 10% phosphate buffered saline solution (PBS). The cells were then 
detached from the flask by adding trypsin-EDTA, harvested, and then re-seeded at 1/4 of their total amount. 
After these processes, we would expect apoptotic cells that are known to detach from the extracellular  matrix34–36 
to be in the cell media suspension and to not initially seed or re-seed after trypsination. The passages (p) were: 
Y101 (p64, p65, p66, p85, p91, p93), Y102 (p66, p79), Y201 (p60, p63), Y202 (p76, p80), CD317+MSC (max. 
p9), K72 (p3–p9) and HDF (p20–p50).
DAPI experiments. The four hTERT MSC-lines (Y101, Y102, Y201 and Y202) were established and main-
tained as described by James et al.14. Cells at 70% confluency were briefly trypsinised; 125,000 cells were applied 
to 13 mm number 1.5 glass coverslips (Scientific Laboratory Supplies) and allowed to adhere for 4  h. Cells 
were fixed with 3% paraformaldehyde (Park Scientific) for 20 min and gently washed 3 × with PBS. DAPI (2 µ
g/ml) was applied for 10 min before an additional 3 × washes in PBS. Coverslips were inverted into vectashield 
mounting media for fluorescence (Vector Laboratories) and imaged at 10× magnification on a Leica DM IRB 
microscope coupled with a Leica DC500 camera. Images were processed in Image J v1.49 (National Institutes 
of Health, USA)37. Briefly, the RGB images were threshold adjusted and particles were analysed with area and 
perimeter measurements being recorded. Images were screened for validity excluding part-cells at the image 
edge, small objects that were not cells, and large objects that were two or more cells that could not be discrimi-
nated. Data from at least 67 cells that met the inclusion criteria were processed in GraphPad Prism v6.07 with 
calculations for average area and perimeter.
Sample preparation for Raman spectroscopy. Harvested cell suspensions were centrifuged for 5 min 
at 1200 rpm to remove the trypsin supernatant and then resuspended in the growth medium. An evenly distrib-
uted single-cell layer required for independent cell measurements was achieved by gentle pipette agitation of the 
cell solution followed by seeding at a density of 5 × 105 cells per calcium fluoride (CaF2 ) microscope slide (75 
mm × 25 mm × 1 mm) (Fig. S21). The slides were then incubated for 24-h in a Petri dish containing 15 mL of 
DMEM supplemented with 15% FBS, 1% penicillin streptomycin and 0.1% Amphotericin B to allow cell attach-
ment. To remove cell-cycle  dependency38, cells were synchronised to the G0-state via nutritional deprivation 
by replacing the culture medium with a 0.5% FBS-concentrated DMEM solution and then re-incubating for a 
24-h39. The microscope slide was then removed from the medium, rinsed twice with PBS and air-desiccated for 
30 min in a fume cupboard. Against fixative solutions, air-drying and desiccation provide good signal intensity 
and preservation of cell components in the Raman  spectrum40. To ensure the highest quality results without 
time-dependent degradation, the spectra were collected from the samples immediately upon being dried.
Raman spectroscopy measurements. Raman point spectra were collected using an HORIBA XploRA 
micro-Raman in confocal setting (100 µ m pinhole), with 200 µ m slit, 532 nm laser wavelength at 3.5 mW laser-
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power and 2400 lines/mm diffraction grating. An 100× (NA = 0.9) objective was used resulting in a diffraction-
limited laser spot size of ∼ 1 µ m. The spectral resolution was 3 cm−1 . Spectra were obtained using 45 s laser 
exposure averaged over two spectral acquisitions. To prevent laser damage, the cells were monitored during 
real-time acquisition to ensure no spectral changes, and optical inspection was also performed after each meas-
urement. Five random spectra were obtained per optically well-defined and demarcated nucleus of randomly 
selected cells per cell population. In the case of label-free Raman measurements, no cell viability assays could be 
used to identify healthy and viable prior to air-dried desiccation. Hence, in addition to cell-culturing processes 
that best removed apoptotic cells due to their detachment (inability to seed), we also excluded from the ran-
dom selection process in the dried-state, those that had morphological features associated with apoptotic cells. 
Namely, we only sampled dried cells with regular, intact edges and surfaces (no evidence of blebbing, excessive 
thickening of the nuclear membrane or significant loss of membrane integrity/leakage) and having intact cel-
lular structure/nucleus (no fractionation) (see Refs.34–36, which describe morphological apoptotic-cell features). 
Convergence of the average spectrum, twice the standard deviation (2×SD) and standard error of the mean (SE) 
for increasing numbers of spectra ensured the data were statistically-representative of the dried-cell state (nuclei 
and cytoplasm). For the hTERT MSCs: Y101 = 555 spectra (six experiments, with several repeats due to its ability 
to spontaneously differentiate), Y201 and Y202 = 180 spectra (two experiments) each, Y102 = 200 spectra (two 
experiments). For the other cell lines: HDFs = 100 spectra (one experiment); CD317+MSCs and K72 popula-
tions = 100 spectra (one experiment) each. For the K72 MSC primaries, 36 spectra/nucleus were obtained from 
three cells, randomly selected. Spatially-resolved Raman maps (360–484 point spectra/map) were also obtained 
from single cells randomly chosen in each hTERT MSC-line population.
Principal component and linear discriminant analyses. PCA and PCA-LDA were performed on the 
Raman results for the hTERT MSCs using R (version 3.3.0)41. Each spectrum was first interpolated using code 
written in IGOR Pro 6.32 to ensure the same wavenumber increments (hence PCA channels) across the spectra. 
The spectra had minimal background removal through linear baselining as this has previously been shown to 
discriminate cell  phenotypes42,43. The five spectra obtained for each single cell nuclei were then averaged using 
IGOR Pro, area-normalised and cubic-spline-smoothed, using 0.65 for the smoothing parameter. Spectral pro-
cessing was performed using the Raman tool set  package44. PCA and LDA plots were produced, as well as the 
corresponding PCA loadings, followed by leave-one-out cross-validation. 18 PCs, accounting for 91% of the 
variance, were incorporated into the LDA as per the protocol in Ref.45.
Peak intensity ratio (PIR) analyses. Each spectrum was linear baseline-corrected from the first to the 
last spectral point using the Raman tool set  package44 and then averaged using IGOR Pro. To determine a statis-
tically-representative number of spectra, convergence tests were performed on the 2 × SD and SE as a function 
of the increasing number of spectra in the spectral average (Figs. S1–S7). Gaussian peak-fitting was performed 
across linear-baselined spectral windows using the IGOR Pro Multipeak Fitting 2 function on each average 
spectrum, with an auto peak-fitting code used for the spatially-resolved maps. PIRs were calculated from the 
intensities determined from the peak fittings, with the uncertainties obtained from the propagated SEs. Raman 
maps were generated from spatially-determined PIRs across the nucleus using an auto-generating procedure 
developed in IGOR Pro. A second convergence test was developed for the %SE for the PIRs (Figs. S15–S20). 
Strict convergence of the statistical quantities ensured experimental variability was fully accounted for as per the 
consistency in results across normalised and non-normalised spectra (e.g., Fig. S22).
PIR panels and KNN classification. PIRs, plus the propagated SE uncertainties, were determined for all-
peaks-against-all-peaks for each hTERT MSC-line. From these PIRs, those that showed Y101/Y201 differentiat-
ing, and/or Y102/Y202 non-differentiating stratification, or individual hTERT MSC-line stratification outside of 
the propagated SE, were used to create the hTERT MSC comparison panels against which the PIRs from other 
cell-types (population-level and individual cells) were compared. To quantify a %-match to each of the hTERT 
MSC-lines, a KNN classification model was devised, whereby the closest nearest neighbour match (both within 
and outside of SE-uncertainty) for each PIR per panel was determined (see e.g., Ref.46 for a description of the 
KNN algorithm).
Data availability
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